PIMA541939
Urelumab Recombinant Human Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA541939-Each-of-1 | In Stock | ₹ 46,245.18 |
PIMA541939 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,245.18
GST (18%): ₹ 8,324.132
Total Price: ₹ 54,569.312
Antigen
Urelumab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
BMS-663513
Immunogen
Human TNFRSF9/CD137
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA, SDS-Page
Concentration
2.45 mg/mL
Formulation
30mM histidine with 0.02% Tween 80, 10% sucrose and no preservative; pH 5.8
Host Species
Human
Purification Method
Protein A
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
IgG4 κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Urelumab has been used in trials studying the treatment of Leukemia, Multiple Myeloma, Malignant Tumors, and Cancer - Solid Tumors and B-Cell Non-Hodgkin's Lymphoma
- Urelumab is a fully human antibody that targets CD137
- The antibody product was developed using Medarex's UltiMAb(R) technology and was the first UltiMAb- derived antibody in clinical development by Bristol-Myers Squibb under the December 2003 agreement with Medarex.
Compare Similar Items
Show Difference
Antigen: Urelumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: BMS-663513
Immunogen: Human TNFRSF9/CD137
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 2.45 mg/mL
Formulation: 30mM histidine with 0.02% Tween 80, 10% sucrose and no preservative; pH 5.8
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG4 κ
Antigen:
Urelumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
BMS-663513
Immunogen:
Human TNFRSF9/CD137
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
2.45 mg/mL
Formulation:
30mM histidine with 0.02% Tween 80, 10% sucrose and no preservative; pH 5.8
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG4 κ
Antigen: Blosozumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: LY2541546
Immunogen: Human SOST(sclerostin)
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 2.42 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG4 κ
Antigen:
Blosozumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
LY2541546
Immunogen:
Human SOST(sclerostin)
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
2.42 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG4 κ
Antigen: Brodalumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: AMG827; KHK4827
Immunogen: Human IL17RA/CD217
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA
Concentration: 2.95 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG2 κ
Antigen:
Brodalumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
AMG827; KHK4827
Immunogen:
Human IL17RA/CD217
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA
Concentration:
2.95 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG2 κ
Antigen: Ficlatuzumab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: AV-299; SCH 900105
Immunogen: Human HGF
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 3.51 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Ficlatuzumab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
AV-299; SCH 900105
Immunogen:
Human HGF
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
3.51 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ